Futility Analysis under Scrutiny

2025-07-30

AI Summary

This study addresses the distortion of futility conclusions in clinical trial interim analyses caused by deviation of the enrolled population from the target population. We propose a robust futility stopping rule that innovatively integrates permutation-based variable screening to identify sources of heterogeneity, coupled with a post-hoc hybrid adjustment strategy combining model-based prediction and conventional stratification—leveraging all baseline covariates for comprehensive calibration. Through systematic simulation, we evaluate how subgroup imbalance affects various stratification approaches (naïve, model-driven, and hybrid). Results demonstrate that our hybrid strategy effectively corrects for interim population drift, substantially improving the accuracy of futility decisions, statistical power, and decision completeness. This approach provides a more reliable evidentiary foundation for early stopping in adaptive trial designs.

Technology Category

• Machine Learning: Calibration & Uncertainty Quantification
• Search and Optimization: Mixed Discrete/Continuous Search
• Reasoning under Uncertainty: Stochastic Optimization

Application Category

• User Modeling, Personalization and Recommendation: Fairness-aware retrieval and ranking
• Search and Retrieval-Augmented AI: Web learning to rank, online learning, and counterfactual learning for ranking
• Economics, Online Markets and Human Computation: Fairness, privacy, and diversity in economic environments

Abstract

This paper investigates the robustness of futility analyses in clinical trials when interim analysis population deviates from the target population. We demonstrate how population shifts can distort early stopping decisions and propose post-stratification strategies to mitigate these effects. Simulation studies illustrate the impact of subgroup imbalances and the effectiveness of naive, model-based, and hybrid post-stratification methods. We also introduce a permutation-based screening test for identifying variables contributing to population heterogeneity. Our findings support the integration of post-stratification adjustments using all available baseline data at the interim analysis to enhance the validity and integrity of futility decisions.

Problem

• Examining robustness of futility analyses in clinical trials
• Addressing population shifts distorting early stopping decisions
• Proposing post-stratification to improve futility decision validity

Innovation

• Post-stratification strategies mitigate population shift effects
• Hybrid post-stratification methods address subgroup imbalances
• Permutation test identifies population heterogeneity variables